Literature DB >> 17451578

Efficacy of pulsed dye laser in facial port-wine stains in Indian patients.

Vinod K Sharma1, Sujay Khandpur.   

Abstract

BACKGROUND: Facial port-wine stain (PWS) produces severe cosmetic disfigurement and pulsed dye laser (PDL) has revolutionized the treatment of PWS.
OBJECTIVE: To assess the efficacy of PDL for facial PWS in Indian patients.
MATERIALS AND METHODS: Twenty-seven patients of Fitzpatrick skin types IV and V in the age group of 8 to 34 years (mean 21.6 years), with lesional size 3 x 1.5 to 25 x 19 cm and color from light pink to deep red and violaceous, were recruited. Laser parameters were spot size, 7 mm; fluence, 5 to 7.5 J/cm(2); wavelength, 585 nm, pulse duration, 0.45 ms; along with continuous air cooling. Response at every session was graded from 0 to 5+(0, no improvement; 1+, up to 25%; 2+, 26% to 50%; 3+, 51% to 75%; 4 +, 76% to 99%; 5+, 100% lightening).
RESULTS: In a total of 170 sessions, maximum response of 1+ was observed in 6 patients after mean of 3.5 sessions, 2+ in 8 patients after mean of 5.25 sessions, 3+ in 8 patients after mean of 7 sessions, and 4+ improvement in 5 patients after mean of 4.8 sessions. No patient showed complete clearance. Seven patients developed hyperpigmentation while 1 patient showed hypopigmentation, but none had textural change or scarring.
CONCLUSION: PDL offers significant cosmetic improvement in facial PWS in Indian patients.

Entities:  

Mesh:

Year:  2007        PMID: 17451578     DOI: 10.1111/j.1524-4725.2007.33114.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  7 in total

Review 1.  An overview of clinical and experimental treatment modalities for port wine stains.

Authors:  Jennifer K Chen; Pedram Ghasri; Guillermo Aguilar; Anne Margreet van Drooge; Albert Wolkerstorfer; Kristen M Kelly; Michal Heger
Journal:  J Am Acad Dermatol       Date:  2012-02-03       Impact factor: 11.527

2.  Does interval time between pulsed dye laser treatments for port-wine stains influence outcome? A systematic review and meta-analysis.

Authors:  Igor Snast; Moshe Lapidoth; Ran Kaftory; Adi Nosrati; Emmilia Hodak; Daniel Mimouni; Efrat Solomon-Cohen; Assi Levi
Journal:  Lasers Med Sci       Date:  2021-02-13       Impact factor: 3.161

Review 3.  An overview of three promising mechanical, optical, and biochemical engineering approaches to improve selective photothermolysis of refractory port wine stains.

Authors:  Guillermo Aguilar; Bernard Choi; Mans Broekgaarden; Owen Yang; Bruce Yang; Pedram Ghasri; Jennifer K Chen; Rick Bezemer; J Stuart Nelson; Anne Margreet van Drooge; Albert Wolkerstorfer; Kristen M Kelly; Michal Heger
Journal:  Ann Biomed Eng       Date:  2011-10-21       Impact factor: 3.934

4.  Treatment of port-wine stains with flash lamp pumped pulsed dye laser on Indian skin: a six year study.

Authors:  Chandroth Ponnambath Thajudheen; Kannangath Jyothy; Arul Priyadarshini
Journal:  J Cutan Aesthet Surg       Date:  2014-01

5.  Clinical outcome measures and scoring systems used in prospective studies of port wine stains: A systematic review.

Authors:  M Ingmar van Raath; Sandeep Chohan; Albert Wolkerstorfer; Chantal M A M van der Horst; Jacqueline Limpens; Xuan Huang; Baoyue Ding; Gert Storm; René R W J van der Hulst; Michal Heger
Journal:  PLoS One       Date:  2020-07-02       Impact factor: 3.240

Review 6.  Site-specific pharmaco-laser therapy: A novel treatment modality for refractory port wine stains.

Authors:  M Ingmar van Raath; Jojanneke E van Amesfoort; Martin Hermann; Yasin Ince; Maurice J Zwart; Agustina V Echague; Yan Chen; Baoyue Ding; Xuan Huang; Gert Storm; Michal Heger
Journal:  J Clin Transl Res       Date:  2019-05-01

7.  Therapeutic Strategies for Untreated Capillary Malformations of the Head and Neck Region: A Systematic Review and Meta-Analyses.

Authors:  Gonca Cinkara; Ginger Beau Langbroek; Chantal M A M van der Horst; Albert Wolkerstorfer; Sophie E R Horbach; Dirk T Ubbink
Journal:  Am J Clin Dermatol       Date:  2021-06-23       Impact factor: 7.403

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.